| 摘要 |
A group of novel phenanthroindolizidine alkaloid compounds as shown and their use in treating cancer. Also disclosed are methods of using phenanthroindolizidine alkoid compounds in suppressing NO and TNF-alpha production, inhibiting MEKK1 activity and cyclooxygenase II expression, and treating NO-related disorders.
|
